ESR1 and breast cancer: The most aggressive type of BC is triple-negative breast cancers (TNBC), characterized by the lack of expression of estrogen receptors (ER), progesterone receptors (PR), and the lack of the overexpression of the human epidermal growth factor receptor 2 (HER2) in the breast tumor [3].